Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

2012122 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Chemotherapy and Pharmacology

Volume 69, Issue 6, pp. 1413-1422

Field-Weighted Citation Impact: 2.15